Izumo, Japan

Yuta Kobayashi

This inventor holds 1 USPTO granted patent. Top assignee: Kyoto Pharmaceutical Industries, Ltd.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuta Kobayashi. Retrieved from https://idiyas.com/inventor/yuta-kobayashi-wa8ypiwb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuta Kobayashi: Innovator in Antirheumatic Agents

Introduction

Yuta Kobayashi is a notable inventor based in Izumo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antirheumatic agents. His work is recognized for its potential impact on treating rheumatic diseases.

Latest Patents

Kobayashi holds a patent for an antirheumatic agent, showcasing his innovative approach to addressing health challenges associated with rheumatic conditions. This patent reflects his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Yuta Kobayashi is currently employed at Kyoto Pharmaceutical Industries, Ltd. His role at the company allows him to engage in cutting-edge research and development, contributing to the pharmaceutical industry’s growth and innovation.

Collaborations

Kobayashi has collaborated with esteemed colleagues, including Fumio Fukata and Hideki Okunishi. These partnerships enhance the collaborative spirit of innovation within the pharmaceutical sector.

Conclusion

Yuta Kobayashi's work in developing antirheumatic agents exemplifies the vital role of inventors in advancing healthcare solutions. His contributions are significant in the ongoing quest for effective treatments for rheumatic diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…